Patent · US Active

Macrocyclic inhibitors of hepatitis C virus

US8227407B2 · kind B2 · utility

1Cited by

8References

16Claims

0Family size

Assignees

MEDIVIR AB · SE
Tibotec BVBA · BE

Inventors

Kenneth Alan Simmen · Tervuren, BE
Herman Augustinus De Kock · Arendonk, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Lili Hu · Mechelen, BE
Dominique Louis Nestor Ghislain Surleraux · Braine-le-Comte, BE
Karl Magnus Nilsson · Vimmerby, SE
Bengt Bertil Samuelsson · Skärholmen, SE
Asa Annica Kristina Rosenquist · Huddinge, SE
Lourdes Salvador Odén · Huddinge, SE

Key dates

Filing date	Jan 16, 2008
Grant date	Jul 24, 2012
Priority date	—
Expiry date	Sep 10, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/06139
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Macrocylic compounds having inhibitory activity on the replication of the hepatitis C virus (HCV) of the general formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.